SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Clinical trials for SQUAMOUS CELL CARCINOMA OF HEAD AND NECK explained in plain language.
Never miss a new study
Get alerted when new SQUAMOUS CELL CARCINOMA OF HEAD AND NECK trials appear
Sign up with your email to follow new studies for SQUAMOUS CELL CARCINOMA OF HEAD AND NECK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug tested for Tough-to-Treat head and neck cancers
Disease control CompletedThis study tested an experimental drug called ozuriftamab vedotin (BA3021) in people with advanced head and neck cancer that had returned or spread. The main goals were to see if the drug could shrink tumors and how safe it was. It included 42 adults whose cancer was not curable …
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Phase: PHASE2 • Sponsor: BioAtla, Inc. • Aim: Disease control
Last updated Apr 02, 2026 02:42 UTC
-
New drug combo tested to fight tough head and neck cancers
Disease control CompletedThis study tested if adding an experimental drug called setanaxib to an existing immunotherapy (pembrolizumab) could help shrink tumors more effectively in patients with advanced head and neck cancer that had returned or spread. It involved 55 patients who were randomly assigned …
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Phase: PHASE2 • Sponsor: Calliditas Therapeutics Suisse SA • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New drug duo tested in battle against Tough-to-Treat head and neck cancer
Disease control CompletedThis study tested whether a combination of two drugs, lenvatinib and pembrolizumab, could help people live longer compared to standard chemotherapy. It involved 408 adults with advanced head and neck cancer that had continued to grow despite previous platinum-based chemotherapy a…
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
First safety test of new cancer drug for chinese patients
Disease control CompletedThis study tested the safety and how the body processes an experimental drug called SGN-B6A in Chinese patients with advanced solid tumors. It involved a small group of 6 participants who had cancers like lung, head and neck, or stomach cancer that had stopped responding to stand…
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Phase: PHASE1 • Sponsor: Seagen, a wholly owned subsidiary of Pfizer • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New Two-Drug combo tested to fight advanced head and neck cancer
Disease control CompletedThis study tested whether adding an experimental drug (tiragolumab) to an existing immunotherapy (atezolizumab) works better than the immunotherapy alone for people with advanced head and neck cancer that has returned or spread. It involved 123 adults whose cancer had a specific …
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New combo therapy tested for tough cancers that resist immunotherapy
Disease control CompletedThis early-stage study tested a new drug, TAK-676, combined with an existing immunotherapy (pembrolizumab) after a short course of radiation. It involved 34 adults with advanced lung cancer, triple-negative breast cancer, or head and neck cancer that had stopped responding to sta…
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Phase: PHASE1 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
First human trial tests new weapon against multiple cancers
Disease control CompletedThis early-stage study aimed to find a safe and effective dose of a new drug called TPST-1495, given alone or with an existing immunotherapy (pembrolizumab), for people with advanced solid tumors. It enrolled 89 adults with cancers like colorectal, lung, and head and neck cancer …
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Phase: PHASE1 • Sponsor: Tempest Therapeutics • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Study asks: how do patients feel about their High-Risk skin cancer care?
Knowledge-focused CompletedThis study aimed to better understand the patient experience for people with a high-risk form of skin cancer on the head or neck. Researchers asked 78 patients to complete surveys about their quality of life, how difficult their treatment decisions were, and how satisfied they we…
Matched conditions: SQUAMOUS CELL CARCINOMA OF HEAD AND NECK
Sponsor: Maastricht University Medical Center • Aim: Knowledge-focused
Last updated Mar 18, 2026 18:25 UTC